Armistice Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5M | Sell |
|
|||||
|
2025
Q1 | $72.3M | Buy |
|
|||||
|
2024
Q4 | $20M | Buy |
|
|||||
|
2024
Q3 | $21.1M | Buy |
|
|||||
|
2024
Q2 | $12.7M | Sell |
|
|||||
|
2024
Q1 | $22.1M | Sell |
|
|||||
|
2023
Q4 | $52.7M | Sell |
|
|||||
|
2023
Q3 | $61.7M | Sell |
|
|||||
|
2023
Q2 | $89.1M | Buy |
|
|||||
|
2023
Q1 | $42.7M | Sell |
|
|||||
|
2022
Q4 | $79.4M | Sell |
|
|||||
|
2022
Q3 | $93.7M | Sell |
|
|||||
|
2022
Q2 | $111K | Buy |
|
|||||
|
2022
Q1 | $58.7M | Sell |
|
|||||
|
2021
Q4 | $73.3M | Buy |
|
|||||
|
2021
Q3 | $60.5M | Sell |
|
|||||
|
2021
Q2 | $87.1M | Sell |
|
|||||
|
2021
Q1 | $82.8M | Buy |
|
|||||
|
2020
Q4 | $63.8M | Buy |
|
|||||
|
2020
Q3 | $47M | Buy |
|
|||||
|
2020
Q2 | $42.4M | Buy |
|
|||||
|
2020
Q1 | $31.3M | Sell |
|
|||||
|
2019
Q4 | $37.5M | Sell |
|
|||||
|
2019
Q3 | $41.1M | Buy |
|
|||||
|
2019
Q2 | $38.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $26.1M | Sell |
|
|||||
|
2018
Q3 | $30.3M | Sell |
|
|||||
|
2018
Q2 | $44.2M | Buy |
|
|||||
|
2018
Q1 | $37.2M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $22.4M | Buy |
|
|||||
|
2017
Q2 | $21.6M | Buy |
|
|||||
|
2017
Q1 | $15.5M | Buy |
|